You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small-cell lung cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participation for Small Cell Lung Cancer Patients

Not yet recruiting
  • Small Cell Lung Cancer
    • (no location specified)
    Mar 3, 2023

    NSCLC Trial in Houston (Amivantamab, Tepotinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Port Saint Lucie, Florida
    • +1 more
    Aug 11, 2023

    NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Tislelizumab IV
    • +2 more
    • (no location specified)
    Oct 25, 2023

    Non Small Cell Lung Cancer Metastatic Trial (MRI)

    Not yet recruiting
    • Non Small Cell Lung Cancer Metastatic
    • MRI
    • (no location specified)
    May 16, 2023

    TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

    Not yet recruiting
    • Lung Cancer, Non-small Cell
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 16, 2022

      Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

      Not yet recruiting
      • Limited-stage Small Cell Lung Cancer (LS-SCLC)
      • Tifcemalimab injection
      • +3 more
      • Jinan, Shandong, China
        Shandong Cancer Hospital & Institute
      Oct 18, 2023

      NSCLC Trial in Beijing

      Recruiting
      • NSCLC
        • Beijing, China
          Yuyan Wang
        Oct 10, 2023

        Integrative Multi-Omics Testing for Immunotherapy Response in

        Recruiting
        • Lung Cancer
          • Guangzhou, Guangdong, China
            Nanfang hospital
          Jun 29, 2023

          Immune-Connected Assays in Small Cell Lung Cancer

          Recruiting
          • Small Cell Lung Cancer
          • Rome, Italy
            Fondazione Policlinico Gemelli IRCCS
          Apr 2, 2023

          NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

          Not yet recruiting
          • NSCLC
          • Non-small Cell Lung Cancer
          • Apatinib + Fluzoparib
          • Apatinib + Fluzoparib + Adebrelimab
          • Guangzhou, Guangdong, China
            Sun Yat-Sen University Cancer Center
          Jun 27, 2023

          NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • +2 more
          • Fairfax, Virginia
            NEXT Virginia
          Sep 18, 2023

          Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

          Not yet recruiting
          • Limited Stage Lung Small Cell Carcinoma
          • +3 more
          • Nashville, Tennessee
            Vanderbilt University/Ingram Cancer Center
          Nov 10, 2023

          Examination of Trends in Non-Small Cell Lung Cancer Patients'

          Not yet recruiting
          • Non-Small Cell Lung Cancer
            • (no location specified)
            Mar 10, 2023

            Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

            Recruiting
            • Non-Small-Cell Lung Cancer
            • Guangzhou, Guangdong, China
              Guangdong General Hospital
            Aug 25, 2023

            Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)

            Not yet recruiting
            • Advanced Non-small-cell Lung Cancer
            • Shanghai, China
              Shanghai Pulmonary Hospital
            Jun 6, 2023

            Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • Propranolol
            • Propranolol hydrochloride
            • +2 more
            • (no location specified)
            Jul 31, 2023

            Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • (no location specified)
            Oct 8, 2023

            Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

            Recruiting
            • Extensive-stage Small Cell Lung Cancer
            • Tianjin, China
              Tianjin Medical University Cancer Institute and Hospital
            Jul 27, 2023

            Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

            Not yet recruiting
            • Non-Small Cell Lung Cancer
            • Oslo, Norway
              Pfizer Norway
            Apr 17, 2023

            NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

            Not yet recruiting
            • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
            • tereotactic body radiotherapy
            • (no location specified)
            Dec 1, 2023

            NSCLC Trial in Shanghai (SI-B001, SI-B003)

            Not yet recruiting
            • Non-small Cell Lung Cancer
            • Shanghai, Shanghai, China
              Shanghai Pulmonary Hospital
            Jul 10, 2023

            Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

            Not yet recruiting
            • Small Cell Lung Cancer
            • +2 more
            • (no location specified)
            Jun 5, 2023

            Non-small Cell Lung Cancer With Central Nervous System

            Recruiting
            • Lung Cancer With Central Nervous System Metastasis
            • lung cancer with brain /leptomeningeal metastasis
            • Taipei, Taiwan
              National Taiwan University Hospital
            Sep 4, 2023

            NSCLC Trial (V940, Pembrolizumab, Placebo)

            Not yet recruiting
            • Non-small Cell Lung Cancer
            • V940
            • +2 more
            • (no location specified)
            Oct 5, 2023